| Literature DB >> 31927136 |
Rupesh Agrawal1, Jianbin Ding2, Parveen Sen3, Andres Rousselot4, Amy Chan5, Lisa Nivison-Smith6, Xin Wei5, Sarakshi Mahajan7, Ramasamy Kim8, Chitaranjan Mishra8, Manisha Agarwal9, Min Hee Suh10, Saurabh Luthra11, Marion R Munk12, Carol Y Cheung13, Vishali Gupta14.
Abstract
The choroid is one of the most vascularized structures of the human body and plays an irreplaceable role in nourishing photoreceptors. As such, choroidal dysfunction is implicated in a multitude of ocular diseases. Studying the choroid can lead to a better understanding of disease pathogenesis, progression and discovery of novel management strategies. However, current research has produced inconsistent findings, partly due to the physical inaccessibility of the choroid and the lack of reliable biomarkers. With the advancements in optical coherence tomography technology, our group has developed a novel quantitative imaging biomarker known as the choroidal vascularity index (CVI), defined as the ratio of vascular area to the total choroidal area. CVI is a potential tool in establishing early diagnoses, monitoring disease progression and prognosticating patients. CVI has been reported in existing literature as a robust marker in numerous retinal and choroidal diseases. In this review, we will discuss the current role of CVI with reference to existing literature, and make postulations about its potential and future applications.Entities:
Keywords: Age related macular degeneration; Artificial intelligence; Choroid; Choroidal vascularity index; Optical coherence tomography; Uveitis
Mesh:
Year: 2020 PMID: 31927136 DOI: 10.1016/j.preteyeres.2020.100829
Source DB: PubMed Journal: Prog Retin Eye Res ISSN: 1350-9462 Impact factor: 21.198